A first-in-man study to evaluate the safety, tolerability, and pharmacokinetics of pasireotide (SOM230), a multireceptor-targeted somatostatin analog, in healthy volunteers

por Golor, Georg, Hu, Ke, Ruffin, Matthieu, Buchelt, Alexandra, Bouillaud, Emmanuel, Wang, Yanfeng, Maldonado, Mario
Publicado 2012